A deep dive into clinical design and therapeutic benefits of complex compounded mitochondrial medicines
Expert Panel on Mitochondrial Medicine
Explore the forefront of compounded mitochondrial medicine with leading experts. Discover how innovative clinical designs and therapeutic strategies are revolutionizing patient care.
Webinar Overview
Advancing Mitochondrial Medicine
This webinar will focus on the latest advancements in mitochondrial medications, exploring the clinical design of mitochondrial compounds and their therapeutic benefits for patients with mitochondrial disorders. Join leading experts as they discuss how these compounds are developed, how active ingredients and dosages are determined, and their impact on patient care.
Our panel will provide insights into the development process of mitochondrial medications and discuss the therapeutic outcomes observed in patients. We will also dive into the compounding process and what compounded medication options are available, as well as insurance coverage. This is a unique opportunity to gain a comprehensive understanding of the field from those at the forefront of mitochondrial medicine.
Key Takeaways
Clinical Design
Understand the innovative clinical designs used in developing mitochondrial medications, including methodologies and protocols used to tailor medication to each patient.
Therapeutic Benefits
Learn about the potential therapeutic benefits of mitochondrial medications, including improved patient outcomes and quality of life for those with mitochondrial disorders.
Q&A Session
Engage with our experts during an interactive Q&A session, where you can ask questions and gain deeper insights into the topics discussed.
Webinar Event Details
Date
September 19, 2024
Time
12:00am – 3:00pm EST
Location
Virtual via Zoho
Meet Our Expert Speakers
Marni Falk, MD
Executive Director, Mitochondrial Medicine Frontier Program
Distinguished Endowed Chair in the Department of Pediatrics
Professor, Division of Human Genetics, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine
The Children’s Hospital of Philadelphia
Amy Goldstein, MD
Clinical Director, Mitochondrial Medicine Frontier Program
Associate Professor of Clinical Pediatrics, Division of Human Genetics, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine
The Children’s Hospital of Philadelphia
Lars Brichta, PharmD, PhD
Chief Scientific Officer and Director of Clinical and Scientific Affairs, Chemistry Rx Pharmacy
CONTACT US
PHONE: +1 (855) 790-0100
EMAIL: info@chemistryrx.com
FAX: 267-861-0862
950 Henderson Blvd.
Folcroft, PA 19032
NAVIGATE
HOURS
MONDAY-FRIDAY
STORE PICK UP: 9am - 6pm
PHONE HOURS: 9am - 8pm
SATURDAY-SUNDAY
CLOSED